0001209191-16-109439.txt : 20160318 0001209191-16-109439.hdr.sgml : 20160318 20160318151941 ACCESSION NUMBER: 0001209191-16-109439 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160316 FILED AS OF DATE: 20160318 DATE AS OF CHANGE: 20160318 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 161515914 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-03-16 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2016-03-16 4 M 0 5130 35.35 A 270414 D Common Stock 2016-03-16 4 S 0 1300 78.07 D 269114 D Common Stock 2016-03-16 4 S 0 1533 79.00 D 267581 D Common Stock 2016-03-16 4 S 0 1197 79.98 D 266384 D Common Stock 2016-03-16 4 S 0 300 81.00 D 266084 D Common Stock 2016-03-16 4 S 0 600 82.27 D 265484 D Common Stock 2016-03-16 4 S 0 200 82.98 D 265284 D Common Stock 13286 I 401k Common Stock 122700 I Common Stock Held In Trust Stock Option (Right to Buy) 35.35 2016-03-16 4 M 0 5130 0.00 D 2016-07-19 Common Stock 5130 82090 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $78.07 (range $77.71 to $78.62). Open market sales reported on this line occurred at a weighted average price of $79.00 (range $78.73 to $79.45). Open market sales reported on this line occurred at a weighted average price of $79.98 (range $79.74 to $80.31). Open market sales reported on this line occurred at a weighted average price of $81.00 (range $80.92 to $81.12). Open market sales reported on this line occurred at a weighted average price of $82.27 (range $81.94 to $82.79). Fully vested. Michael LaCascia, Attorney-In-Fact 2016-03-18